Literature DB >> 30712011

Effect of balloon guide catheter on clinical outcomes and reperfusion in Trevo thrombectomy.

Thanh N Nguyen1,2,3, Alicia C Castonguay4, Raul G Nogueira5, Diogo C Haussen5, Joey D English6, Sudhakar R Satti7, Jennifer Chen8, Hamed Farid9, Candace Borders10, Erol Veznedaroglu11, Mandy J Binning11, Ajit S Puri12, Nirav A Vora13, Ron F Budzik13, Guilherme Dabus14, Italo Linfante14, Vallabh Janardhan15, Amer Alshekhlee16, Michael G Abraham17, Randall C Edgell18, M Asif Taqi19, Ramy El Khoury20, Maxim Mokin21, Aniel Q Majjhoo22, Mouhammed R Kabbani23, Michael T Froehler24, Ira Finch25, Sameer A Ansari26, Roberta Novakovic27, Mohamad Abdalkader1,2,3, Osama O Zaidat28.   

Abstract

INTRODUCTION: The Solitaire stent retriever registry showed improved reperfusion, faster procedure times, and better outcome in acute stroke patients with large vessel occlusion treated with a balloon guide catheter (BGC) and Solitaire stent retriever compared with a conventional guide catheter. The goal of this study was to evaluate whether use of a BGC with the Trevo stent retriever improves outcomes compared with a conventional guide catheter.
METHODS: The TRACK registry recruited 23 sites to submit demographic, clinical, and site adjudicated angiographic and outcome data on consecutive patients treated with the Trevo stent retriever. BGC use was at the discretion of the physician.
RESULTS: 536 anterior circulation patients (of whom 279 (52.1%) had BGC placement) were included in this analysis. Baseline characteristics were notable for younger patients in the BGC group (65.4±15.3 vs 68.1±13.6, P=0.03) and lower rate of hypertension (72% vs 79%, P=0.06). Mean time from symptom onset to groin puncture was longer in the BGC group (357 vs 319 min, P=0.06).Thrombolysis in Cerebral Infarction 2b/3 scores were higher in the BGC cohort (84% vs 75.5%, P=0.01). There was no difference in reperfusion time, first pass effect, number of passes, or rescue therapy. Good clinical outcome at 3 months was superior in patients with BGC (57% vs 40%; P=0.0004) with a lower mortality rate (13% vs 23%, P=0.008). Multivariate analysis demonstrated that BGC use was an independent predictor of good clinical outcome (OR 2; 95% CI 1.3 to 3.1, P=0.001).
CONCLUSIONS: In acute stroke patients presenting with anterior circulation large vessel occlusion, use of a BGC with the Trevo stent retriever resulted in improved reperfusion, improved clinical outcome, and lower mortality. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  balloon; catheter; stroke; technique; thrombectomy

Mesh:

Year:  2019        PMID: 30712011     DOI: 10.1136/neurintsurg-2018-014452

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  10 in total

1.  Balloon guide catheters: use, reject, or randomize?

Authors:  Mayank Goyal; Manon Kappelhof; Johanna M Ospel; Fouzi Bala
Journal:  Neuroradiology       Date:  2021-06-08       Impact factor: 2.804

2.  Biomechanics and hemodynamics of stent-retrievers.

Authors:  Anna Luisa Kühn; Zeynep Vardar; Afif Kraitem; Robert M King; Vania Anagnostakou; Ajit S Puri; Matthew J Gounis
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-19       Impact factor: 6.200

Review 3.  Evolution of Stroke Thrombectomy Techniques to Optimize First-Pass Complete Reperfusion.

Authors:  Johanna Maria Ospel; Ryan McTaggart; Nima Kashani; Marios Psychogios; Mohammed Almekhlafi; Mayank Goyal
Journal:  Semin Intervent Radiol       Date:  2020-05-14       Impact factor: 1.513

4.  Duration of symptomatic stroke and successful reperfusion with endovascular thrombectomy for anterior circulation large vessel occlusive stroke.

Authors:  Adam de Havenon; Matthew D Alexander; Raul G Nogueira; Diogo C Haussen; Alicia C Castonguay; Italo Linfante; Michael Austin Johnson; Thanh N Nguyen; Maxim Mokin; Osama O Zaidat
Journal:  J Neurointerv Surg       Date:  2021-02-01       Impact factor: 5.836

5.  Clinical and Procedural Outcomes with or without Balloon Guide Catheters during Endovascular Thrombectomy in Acute Ischemic Stroke: A Systematic Review and Meta-analysis with First-line Technique Subgroup Analysis.

Authors:  A Podlasek; P S Dhillon; G Jewett; A Shahein; M Goyal; M Almekhlafi
Journal:  AJNR Am J Neuroradiol       Date:  2021-05-27       Impact factor: 4.966

6.  Systematic review and meta-analysis of current rates of first pass effect by thrombectomy technique and associations with clinical outcomes.

Authors:  Mehdi Abbasi; Yang Liu; Seán Fitzgerald; Oana Madalina Mereuta; Jorge L Arturo Larco; Asim Rizvi; Ramanathan Kadirvel; Luis Savastano; Waleed Brinjikji; David F Kallmes
Journal:  J Neurointerv Surg       Date:  2021-01-13       Impact factor: 8.572

7.  Effect of Balloon Guide Catheter Utilization on the Incidence of Sub-angiographic Peripheral Emboli on High-Resolution DWI After Thrombectomy: A Prospective Observational Study.

Authors:  Michael H Schönfeld; Reza Kabiri; Helge C Kniep; Lukas Meyer; Rosalie McDonough; Jan Sedlacik; Marielle Ernst; Gabriel Broocks; Tobias Faizy; Gerhard Schön; Bastian Cheng; Götz Thomalla; Jens Fiehler; Uta Hanning
Journal:  Front Neurol       Date:  2020-05-07       Impact factor: 4.003

Review 8.  The Next Step in the Treatment of Stroke.

Authors:  Nathanael Matei; Justin Camara; John H Zhang
Journal:  Front Neurol       Date:  2021-01-22       Impact factor: 4.003

9.  Comparing the Conventional and Balloon-Guided Catheter-Assisted SWIM Technology for the Treatment of Acute Ischemic Stroke.

Authors:  Zhengwen Chen; Yizhi Liu; Bo Li; Chen Yuan; Kaiwen Hou; Long Chen; Peicheng Li
Journal:  Front Neurol       Date:  2022-07-13       Impact factor: 4.086

10.  Predictors of Successful First-Pass Thrombectomy with a Balloon Guide Catheter: Results of a Decision Tree Analysis.

Authors:  Aglaé Velasco Gonzalez; Dennis Görlich; Boris Buerke; Nico Münnich; Cristina Sauerland; Thilo Rusche; Andreas Faldum; Walter Heindel
Journal:  Transl Stroke Res       Date:  2020-05-23       Impact factor: 6.800

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.